Human Technopole

An international collaboration between Human Technopole and Erasmus Medical Centre researchers sheds light on the molecular mechanisms underlying the transport of thyroid hormones in human cells by monocarboxylate transporters (MCTs). The results of the research are published in Nature Communications.

After the success of its inaugural edition, which gathered over 100 participants, the HT PhD Student & Postdoc Symposium returns for its second year on 30 September 2025. Join us in supporting the future of life sciences. Every contribution can make a difference!  

On 27 and 28 March, the SIEC (Standing Independent Evaluation Committee), visited HT to discuss the results of the first call for access, which was considered a pilot phase, and refine the upcoming call, planned to be published at the beginning of June 2025. 

Human Technopole has presented 102 research projects that were the first to benefit from the cutting-edge equipment of the National Facilities — the advanced technologies that the Institute makes available to external researchers from across Italy. The majority of studies focus on cancer and neurodegenerative diseases, accounting for 50% of the selected projects. The announcement was made this morning in Milan during “Open HT – The Open Day on Life Sciences”, an event designed to showcase Human Technopole’s achievements and outline future goals.

Human Technopole is offering up to 10 fully funded PhD scholarships through the SEMM PhD Program in Systems Medicine. These scholarships are open to talented and motivated graduates—both from Italy and abroad – interested in pursuing doctoral research.

Using advanced stem cell models, Human Technopole researchers show how mutations in the YY1 gene cause widespread dysregulation of genes crucial for brain development in multiple cell types, leading to structural abnormalities and impaired neuronal function. The results of the research are published in the Nature Portfolio journal Molecular Psychiatry.